|
Eli Lilly and Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$987
|
$966B |
15.2x |
33.5x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$243
|
$615B |
6.6x |
17.2x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$232
|
$472B |
7.7x |
18.1x |
|
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 361
|
$398B |
4.9x |
12.5x |
|
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£151
|
$345B |
5.8x |
16.7x |
|
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 125
|
$335B |
5.9x |
14.2x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$121
|
$325B |
5.0x |
10.9x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$369
|
$244B |
6.7x |
13.8x |
|
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 311
|
$237B |
4.8x |
10.0x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$155
|
$210B |
7.2x |
13.1x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$28
|
$203B |
3.3x |
8.2x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$61
|
$160B |
3.3x |
8.6x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£22
|
$138B |
3.1x |
9.2x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€78
|
$127B |
2.4x |
7.9x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$491
|
$120B |
10.0x |
22.2x |
|
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€46
|
$92.6B |
1.7x |
8.1x |
|
Chugai Pharmaceutical Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 9280
|
$91.5B |
11.5x |
22.6x |
|
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 5614
|
$83.0B |
2.9x |
10.6x |
|
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$803
|
$79.0B |
5.6x |
15.8x |
|
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€128
|
$77.1B |
3.1x |
10.6x |
|
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$60.5B |
4.0x |
15.9x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$127
|
$60.4B |
6.4x |
14.7x |
|
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 104
|
$53.0B |
3.0x |
10.1x |
|
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 58
|
$50.1B |
10.5x |
34.8x |
|
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 152
|
$49.0B |
9.1x |
39.6x |
|
argenx
|
Belgium |
Drug Development & Therapeutics
|
€709
|
$48.3B |
11.3x |
39.8x |
|
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€51
|
$47.1B |
1.8x |
10.4x |
|
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1698
|
$42.2B |
6.8x |
23.9x |
|
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 66
|
$41.2B |
3.6x |
16.7x |
|
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$314
|
$40.1B |
10.7x |
57.1x |
|
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 217
|
$37.0B |
7.0x |
70.5x |
|
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 10585
|
$33.6B |
2.2x |
8.9x |
|
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2937
|
$32.4B |
2.5x |
12.2x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$16
|
$31.7B |
2.3x |
7.7x |
|
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2511
|
$31.7B |
2.5x |
10.4x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$197
|
$31.6B |
3.2x |
10.4x |
|
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$149
|
$30.7B |
59.6x |
-27.4x |
|
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 36
|
$23.7B |
11.3x |
29.3x |
|
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 8
|
$21.9B |
2.1x |
6.0x |
|
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 89
|
$18.6B |
9.6x |
107.0x |
|
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€10
|
$17.8B |
2.0x |
8.2x |
|
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6169
|
$17.7B |
15.5x |
47.6x |
|
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$474
|
$17.3B |
5.4x |
10.3x |
|
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 408
|
$17.0B |
5.3x |
13.8x |
|
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$96
|
$16.9B |
4384.8x |
-14.9x |
|
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 287
|
$16.8B |
52.5x |
N/A |
|
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$101
|
$16.6B |
3.3x |
10.5x |
|
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$25
|
$16.0B |
3.4x |
18.0x |
|
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$75
|
$15.6B |
31.7x |
-34.1x |
|
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 3536
|
$15.6B |
5.0x |
12.5x |
|
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1904
|
$15.4B |
4.1x |
10.9x |
|
Torrent Pharmaceuticals
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 4078
|
$15.4B |
11.1x |
33.6x |
|
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$15.4B |
N/A |
N/A |
|
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 168
|
$14.6B |
10.1x |
31.9x |
|
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$26
|
$14.5B |
790.6x |
-13.0x |
|
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€155
|
$14.5B |
3.2x |
8.5x |
|
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€48
|
$14.1B |
4.5x |
12.0x |
|
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 7
|
$13.8B |
2.9x |
10.7x |
|
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€182
|
$13.6B |
N/A |
N/A |
|
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$166
|
$13.5B |
3.2x |
14.3x |
|
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 10
|
$13.4B |
3.4x |
13.5x |
|
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 25
|
$12.9B |
2.2x |
13.5x |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$42
|
$12.7B |
6.6x |
-4.0x |
|
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$81
|
$12.3B |
13.7x |
-33.3x |
|
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 105
|
$12.0B |
25.5x |
-1201.8x |
|
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 419
|
$11.9B |
42.5x |
-257.1x |
|
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.8B |
0.3x |
5.0x |
|
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€68
|
$11.5B |
5.1x |
13.8x |
|
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1268
|
$11.5B |
3.1x |
12.5x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$124
|
$11.4B |
4.0x |
17.3x |
|
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2199
|
$11.0B |
4.0x |
15.5x |
|
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$15
|
$10.9B |
N/A |
-10.6x |
|
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1331
|
$10.7B |
3.4x |
14.0x |
|
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$60
|
$10.6B |
3.3x |
14.3x |
|
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$44
|
$10.5B |
4.5x |
11.2x |
|
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 905
|
$10.3B |
3.7x |
13.4x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$79
|
$10.2B |
7.6x |
11.6x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$10.1B |
1.6x |
5.2x |
|
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2060
|
$9.9B |
6.4x |
25.7x |
|
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$465
|
$9.8B |
10.3x |
-33.3x |
|
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$106
|
$9.6B |
3.1x |
-7.8x |
|
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$73
|
$9.4B |
485.0x |
-14.0x |
|
Abivax
|
France |
Drug Development & Therapeutics,
Biopharmaceuticals
|
€106
|
$9.3B |
905.1x |
-38.4x |
|
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$181
|
$9.0B |
14.4x |
-55.1x |
|
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 36
|
$8.8B |
1.4x |
11.0x |
|
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 5066
|
$8.6B |
1.7x |
13.6x |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$317
|
$8.5B |
28552.0x |
-28.7x |
|
Samchundang Pharm
|
South Korea |
Drug Development & Therapeutics
|
KRW 535000
|
$8.5B |
N/A |
N/A |
|
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$64
|
$8.3B |
11.5x |
208.0x |
|
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$66
|
$8.3B |
103.5x |
-13.8x |
|
Salubris Pharmaceuticals
|
China |
Drug Development & Therapeutics,
Medical Devices
|
CNY 51
|
$8.0B |
12.2x |
50.3x |
|
Haisco Pharmaceutical
|
China |
Drug Development & Therapeutics
|
CNY 48
|
$7.9B |
12.2x |
70.5x |
|
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€235
|
$7.8B |
3.3x |
9.8x |
|
Caliway Biopharmaceuticals
|
Taiwan |
Drug Development & Therapeutics
|
TWD 160
|
$7.7B |
6367.5x |
-276.8x |
|
Kyowa Kirin Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2691
|
$7.6B |
2.5x |
10.9x |
|
Sumitomo Pharma
|
Japan |
Drug Development & Therapeutics
|
JPY 2470
|
$7.5B |
2.7x |
10.1x |
|
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 38
|
$7.4B |
N/A |
N/A |
|
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$277
|
$7.3B |
18.8x |
43.5x |
|
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2536
|
$7.2B |
2.3x |
9.5x |
|
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1146
|
$7.2B |
2.0x |
9.6x |